+Compare
ICAD
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
50.27M

ICAD iCAD Forecast, Technical & Fundamental Analysis

a provider of computer-aided detection solutions

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for ICAD with price predictions
08:00 PM EDT Sep 25, 2023

ICAD sees its Stochastic Oscillator ascending out of oversold territory

On September 26, 2023, the Stochastic Oscillator for ICAD moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 70 instances where the indicator left the oversold zone. In of the 70 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ICAD's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 26, 2023. You may want to consider a long position or call options on ICAD as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ICAD just turned positive on September 26, 2023. Looking at past instances where ICAD's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ICAD advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

ICAD moved below its 50-day moving average on August 24, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ICAD crossed bearishly below the 50-day moving average on August 28, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICAD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ICAD entered a downward trend on September 26, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.666) is normal, around the industry mean (24.932). P/E Ratio (0.000) is within average values for comparable stocks, (79.196). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.230). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (2.052) is also within normal values, averaging (58.009).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ICAD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICAD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.32B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -2%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -9%. FEMY experienced the highest price growth at 363%, while RHNMF experienced the biggest fall at -54%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 62% and the average quarterly volume growth was 174%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 72
Price Growth Rating: 66
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

ICAD is expected to report earnings to fall 29.42% to -8 cents per share on November 09

iCAD ICAD Stock Earnings Reports
Q3'23
Est.
$-0.08
Q2'23
Missed
by $0.01
Q1'23
Missed
by $0.03
Q4'22
Beat
by $0.03
Q3'22
Missed
by $0.02
The last earnings report on August 14 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 71.64K shares outstanding, the current market capitalization sits at 50.27M.
A.I. Advisor
published General Information

General Information

a provider of computer-aided detection solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Computer Peripherals
Address
98 Spit Brook Road
Phone
+1 603 882-5200
Employees
109
Web
https://www.icadmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBDC13.89-0.03
-0.22%
Blue Owl Capital Corp
COST552.96-5.66
-1.01%
Costco Wholesale Corp
PFIS43.78-0.60
-1.35%
Peoples Financial Services Corp
TRMK20.99-0.42
-1.96%
Trustmark Corp
STRM0.79-0.03
-3.65%
Streamline Health Solutions

ICAD and

Correlation & Price change

A.I.dvisor tells us that ICAD and HAE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ICAD and HAE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICAD
1D Price
Change %
ICAD100%
+3.02%
HAE - ICAD
32%
Poorly correlated
-3.73%
ILMN - ICAD
29%
Poorly correlated
-1.90%
NARI - ICAD
29%
Poorly correlated
+0.45%
CVRX - ICAD
27%
Poorly correlated
+3.19%
CTKB - ICAD
26%
Poorly correlated
-1.40%
More

Groups containing ICAD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICAD
1D Price
Change %
ICAD100%
+3.02%
computers
(undefined stocks)
19%
Poorly correlated
+0.65%
peripheral
(undefined stocks)
18%
Poorly correlated
+1.33%
Medical Specialties
(undefined stocks)
18%
Poorly correlated
+0.11%
Medical Specialties
(undefined stocks)
18%
Poorly correlated
+0.11%